sukeshemana Introduction: A Critical Moment in Global Health
On August 14, 2024, the World Health Organization (WHO) declared the Mpox Outbreak Emergency of International Concern (PHEIC), marking a significant escalation in the global health response. This decision underscores the severity of the outbreak that has intensified in the Democratic Republic of the Congo (DRC) and has spread to neighboring countries in Africa. The declaration follows a comprehensive review by the WHO’s International Health Regulations (IHR) Emergency Committee, emphasizing the urgent need for an international response to contain and mitigate the crisis.
Understanding Mpox and Its Recent Surge
Mpox, an infectious disease caused by the Orthopoxvirus, was first detected in humans in 1970 in the DRC. Historically, mpox has been endemic to central and west Africa, but recent developments have drawn significant global attention. The disease caused a multi-country outbreak in 2022, which was initially declared a PHEIC but was later lifted in May 2023 following a global decline in cases.
However, the current surge in mpox cases is alarming. With over 15,600 cases and 537 deaths reported globally this year alone, the situation is deteriorating rapidly. The emergence of clade 1b, a new strain of mpox primarily transmitted through sexual networks, has heightened concerns. This strain has been detected in Burundi, Kenya, Rwanda, and Uganda—countries that had previously reported no cases of mpox. The rapid spread of clade 1b underscores the urgent need for a coordinated global response.
The WHO’s Urgent Response
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, announced the PHEIC, stressing the critical nature of the outbreak. He emphasized, “The emergence of a new clade of mpox, its rapid spread in eastern DRC, and the reporting of cases in several neighboring countries are very worrying.” Dr. Tedros’s declaration highlights the necessity for a unified global effort to manage and contain the outbreak effectively.
In response, the WHO is enhancing surveillance and strengthening response measures in affected regions. The WHO Regional Director for Africa, Dr. Matshidiso Moeti, has confirmed that significant efforts are underway, but the situation requires further international support. Dr. Moeti stated, “With the growing spread of the virus, we’re scaling up further through coordinated international action to support countries bring the outbreaks to an end.”
International Coordination and Vaccine Efforts
To combat the crisis, the WHO has initiated several measures, including expediting Emergency Use Listing (EUL) for mpox vaccines. This initiative aims to facilitate the rapid availability of vaccines, particularly for lower-income countries that have yet to authorize the vaccines nationally. The WHO is working with partners like Gavi and UNICEF to procure and distribute vaccines.
Currently, two vaccines are recommended by the WHO’s Strategic Advisory Group of Experts on Immunization. These vaccines are essential in controlling the outbreak. The WHO’s emergency response includes efforts to secure vaccine donations and coordinate distribution through the interim Medical Countermeasures Network, which focuses on ensuring equitable access to vaccines, therapeutics, diagnostics, and other essential tools.
Financial and Logistical Challenges
The WHO has identified an immediate funding requirement of $15 million to support global surveillance, preparedness, and response activities. In response to the urgent need, the organization has released $1.45 million from the WHO Contingency Fund for Emergencies and is appealing to donors for additional support. This funding is crucial for effective response efforts and resource allocation.
The Global and Regional Impact of the Mpox Outbreak
The mpox outbreak’s impact extends beyond the immediate region, potentially posing a global health risk. The disease’s rapid spread highlights the interconnectedness of health threats and the importance of global solidarity in response efforts. Strengthening health systems and improving preparedness are vital to managing the current crisis and preventing future outbreaks.
Updated Developments: August 2024
As of late August 2024, the outbreak continues to evolve. New cases and regions are being reported, and international health agencies are closely monitoring the situation. The WHO is actively engaged in ongoing assessments and updates to respond to the dynamic nature of the outbreak.
Timeline of Key Developments
- 1970: Mpox first detected in humans in the DRC.
- July 2022: The multi-country mpox outbreak declared a PHEIC due to its rapid spread.
- May 2023: The PHEIC for the 2022 outbreak was declared over following a decline in global cases.
- August 14, 2024: New PHEIC declaration due to the surge in cases and the emergence of clade 1b in Africa.
- Ongoing: WHO’s response includes vaccine distribution, international coordination, and funding appeals.
Expert Opinions on the Mpox Outbreak
Several experts have weighed in on the current mpox crisis:
- Professor Dimie Ogoina, Chair of the IHR Emergency Committee, remarked, “The current upsurge of mpox in parts of Africa, along with the spread of a new sexually transmissible strain of the monkeypox virus, is an emergency not only for Africa but for the entire globe.”
- Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, emphasized the need for international action, stating, “It’s clear that a coordinated international response is needed to stop these outbreaks and save lives.”
Conclusion: A Call to Action
The WHO’s declaration of mpox as a Public Health Emergency of International Concern marks a pivotal moment in the global health response. With the outbreak showing no signs of abating, it is imperative that international communities and organizations unite in a concerted effort to manage and ultimately contain the crisis. Scaling up vaccination efforts, improving surveillance, and securing necessary funding are critical in addressing the immediate needs of affected regions and preventing further spread. Continued global cooperation and support will be essential in overcoming this health emergency and safeguarding public health worldwide.
References and Further Reading
For Regular Health Tips Follow – ResCure
FAQs
Q1: What is mpox, and how does it spread?
Mpox, formerly known as monkeypox, is an infectious disease caused by the Orthopoxvirus. It primarily spreads through close contact with infected individuals, bodily fluids, or contaminated surfaces. Recent outbreaks have also highlighted the virus’s transmission through sexual networks, particularly with the emergence of the new clade 1b.
Q2: Why did the WHO declare a PHEIC for mpox in August 2024?
The WHO declared a Public Health Emergency of International Concern (PHEIC) due to the significant surge in mpox cases in the DRC and neighboring countries. The rapid spread of a new strain, clade 1b, and its potential to affect global health prompted this urgent response to coordinate international efforts.
Q3: What are the key strategies in the WHO’s response to the mpox outbreak?
The WHO’s strategies include scaling up vaccination efforts, expediting Emergency Use Listing (EUL) for vaccines, enhancing global surveillance, and securing financial support. The organization is also working with international partners to ensure equitable distribution of vaccines and resources.
Q4: How is the WHO working to support countries affected by mpox?
The WHO supports affected countries by providing financial aid, enhancing surveillance, and coordinating with local health authorities to strengthen response measures. The organization is also facilitating vaccine distribution and working with partners like Gavi and UNICEF to address resource needs.
Q5: What is the current status of mpox vaccines and their availability?
Two vaccines for mpox are recommended by the WHO. The WHO is working to expedite their availability through Emergency Use Listing, especially for lower-income countries. Efforts are underway to secure and distribute vaccines via international partnerships to ensure timely access.